MAGNUM OPUS ACQUISITION LT-A (OPA) Stock Fundamental Analysis

NYSE:OPA • KYG5S70A1049

10.795 USD
+0.01 (+0.05%)
Last: Jan 23, 2024, 07:53 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

1

Taking everything into account, OPA scores 1 out of 10 in our fundamental rating. OPA was compared to 0 industry peers in the Unkown industry. Both the profitability and financial health of OPA have multiple concerns. OPA is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

  • OPA had positive earnings in the past year.
  • In the past year OPA has reported a negative cash flow from operations.
OPA Yearly Net Income VS EBIT VS OCF VS FCFOPA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 0 5M -5M 10M 15M

1.2 Ratios

Industry RankSector Rank
ROA 22.76%
ROE 28.85%
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
OPA Yearly ROA, ROE, ROICOPA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 0 2 -2 4 6

1.3 Margins

  • The Profit Margin and Operating Margin and Gross Margin are not available for OPA so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
OPA Yearly Profit, Operating, Gross MarginsOPA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

2

2. Health

2.1 Basic Checks

  • Compared to 1 year ago, OPA has about the same amount of shares outstanding.
  • The debt/assets ratio for OPA is higher compared to a year ago.
OPA Yearly Shares OutstandingOPA Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 5M 10M 15M 20M
OPA Yearly Total Debt VS Total AssetsOPA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 50M 100M 150M 200M

2.2 Solvency

  • An Altman-Z score of 4.34 indicates that OPA is not in any danger for bankruptcy at the moment.
  • OPA has a Debt/Equity ratio of 0.01. This is a healthy value indicating a solid balance between debt and equity.
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF N/A
Altman-Z 4.34
ROIC/WACCN/A
WACCN/A
OPA Yearly LT Debt VS Equity VS FCFOPA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 0 50M 100M 150M

2.3 Liquidity

  • OPA has a Current Ratio of 0.07. This is a bad value and indicates that OPA is not financially healthy enough and could expect problems in meeting its short term obligations.
  • OPA has a Quick Ratio of 0.07. This is a bad value and indicates that OPA is not financially healthy enough and could expect problems in meeting its short term obligations.
Industry RankSector Rank
Current Ratio 0.07
Quick Ratio 0.07
OPA Yearly Current Assets VS Current LiabilitesOPA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2M 4M 6M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

1

3. Growth

3.1 Past

  • OPA shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 287.50%, which is quite impressive.
EPS 1Y (TTM)287.5%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%100%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y26.47%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
OPA Yearly Revenue VS EstimatesOPA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2022 2023 50M 100M 150M 200M 250M
OPA Yearly EPS VS EstimatesOPA Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 0.1 0.2 0.3 0.4

More info and screens

Find the best growth stocksShow best growing peers

2

4. Valuation

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 17.41, the valuation of OPA can be described as rather expensive.
  • Compared to an average S&P500 Price/Earnings ratio of 27.09, OPA is valued a bit cheaper.
  • With a Price/Forward Earnings ratio of 24.86, OPA is valued on the expensive side.
  • OPA's Price/Forward Earnings ratio indicates a similar valuation than the S&P500 average which is at 27.98.
Industry RankSector Rank
PE 17.41
Fwd PE 24.86
OPA Price Earnings VS Forward Price EarningsOPA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
OPA Per share dataOPA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2 3 4

4.3 Compensation for Growth

  • The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
PEG (NY)0.66
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • No dividends for OPA!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

Find the best dividend stocksShow peers with best dividend

MAGNUM OPUS ACQUISITION LT-A

NYSE:OPA (1/23/2024, 7:53:27 PM)

10.795

+0.01 (+0.05%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)11-14
Earnings (Next)04-02
Inst Owners0.47%
Inst Owner Change-64.07%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap119.72M
Revenue(TTM)N/A
Net Income(TTM)15.52M
Analysts80
Price Target15.3 (41.73%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 17.41
Fwd PE 24.86
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 2.23
P/tB 2.23
EV/EBITDA N/A
EPS(TTM)0.62
EY5.74%
EPS(NY)0.43
Fwd EY4.02%
FCF(TTM)-0.13
FCFYN/A
OCF(TTM)-0.13
OCFYN/A
SpS0
BVpS4.85
TBVpS4.85
PEG (NY)0.66
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA 22.76%
ROE 28.85%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.07
Quick Ratio 0.07
Altman-Z 4.34
F-Score5
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)287.5%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%100%
EPS Next Y26.47%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y11.48%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year65.6%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-49.53%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-49.53%
OCF growth 3YN/A
OCF growth 5YN/A

MAGNUM OPUS ACQUISITION LT-A / OPA FAQ

Can you provide the ChartMill fundamental rating for MAGNUM OPUS ACQUISITION LT-A?

ChartMill assigns a fundamental rating of 1 / 10 to OPA.


What is the valuation status of MAGNUM OPUS ACQUISITION LT-A (OPA) stock?

ChartMill assigns a valuation rating of 2 / 10 to MAGNUM OPUS ACQUISITION LT-A (OPA). This can be considered as Overvalued.


What is the profitability of OPA stock?

MAGNUM OPUS ACQUISITION LT-A (OPA) has a profitability rating of 0 / 10.


Can you provide the PE and PB ratios for OPA stock?

The Price/Earnings (PE) ratio for MAGNUM OPUS ACQUISITION LT-A (OPA) is 17.41 and the Price/Book (PB) ratio is 2.23.


What is the earnings growth outlook for MAGNUM OPUS ACQUISITION LT-A?

The Earnings per Share (EPS) of MAGNUM OPUS ACQUISITION LT-A (OPA) is expected to grow by 26.47% in the next year.